183 related articles for article (PubMed ID: 21938511)
21. Plasma Cells Are the Most Abundant Gluten Peptide MHC-expressing Cells in Inflamed Intestinal Tissues From Patients With Celiac Disease.
Høydahl LS; Richter L; Frick R; Snir O; Gunnarsen KS; Landsverk OJB; Iversen R; Jeliazkov JR; Gray JJ; Bergseng E; Foss S; Qiao SW; Lundin KEA; Jahnsen J; Jahnsen FL; Sandlie I; Sollid LM; Løset GÅ
Gastroenterology; 2019 Apr; 156(5):1428-1439.e10. PubMed ID: 30593798
[TBL] [Abstract][Full Text] [Related]
22. Broad MICA/B expression in the small bowel mucosa: a link between cellular stress and celiac disease.
Allegretti YL; Bondar C; Guzman L; Cueto Rua E; Chopita N; Fuertes M; Zwirner NW; Chirdo FG
PLoS One; 2013; 8(9):e73658. PubMed ID: 24058482
[TBL] [Abstract][Full Text] [Related]
23. Intestinal Production of Anti-Tissue Transglutaminase 2 Antibodies in Patients with Diagnosis Other Than Celiac Disease.
Maglio M; Ziberna F; Aitoro R; Discepolo V; Lania G; Bassi V; Miele E; Not T; Troncone R; Auricchio R
Nutrients; 2017 Sep; 9(10):. PubMed ID: 28934109
[TBL] [Abstract][Full Text] [Related]
24. IL-15-dependent activation-induced cell death-resistant Th1 type CD8 alpha beta+NK1.1+ T cells for the development of small intestinal inflammation.
Ohta N; Hiroi T; Kweon MN; Kinoshita N; Jang MH; Mashimo T; Miyazaki J; Kiyono H
J Immunol; 2002 Jul; 169(1):460-8. PubMed ID: 12077277
[TBL] [Abstract][Full Text] [Related]
25. Gluten: a two-edged sword. Immunopathogenesis of celiac disease.
Koning F; Gilissen L; Wijmenga C
Springer Semin Immunopathol; 2005 Sep; 27(2):217-32. PubMed ID: 16091925
[TBL] [Abstract][Full Text] [Related]
26. Gluten-dependent intestinal autoimmune response.
Korponay-Szabó IR; Simon-Vecsei Z; De Leo L; Not T
Curr Pharm Des; 2012; 18(35):5753-8. PubMed ID: 22726113
[TBL] [Abstract][Full Text] [Related]
27. Gliadin intake alters the small intestinal mucosa in indomethacin-treated HLA-DQ8 transgenic mice.
Mazzarella G; Bergamo P; Maurano F; Luongo D; Rotondi Aufiero V; Bozzella G; Palmieri G; Troncone R; Auricchio S; David C; Rossi M
Am J Physiol Gastrointest Liver Physiol; 2014 Aug; 307(3):G302-12. PubMed ID: 24924747
[TBL] [Abstract][Full Text] [Related]
28. Management of celiac disease in daily clinical practice.
Elli L; Ferretti F; Orlando S; Vecchi M; Monguzzi E; Roncoroni L; Schuppan D
Eur J Intern Med; 2019 Mar; 61():15-24. PubMed ID: 30528262
[TBL] [Abstract][Full Text] [Related]
29. Tissue transglutaminase in celiac disease: role of autoantibodies.
Caputo I; Barone MV; Martucciello S; Lepretti M; Esposito C
Amino Acids; 2009 Apr; 36(4):693-9. PubMed ID: 18600381
[TBL] [Abstract][Full Text] [Related]
30. Celiac anti-type 2 transglutaminase antibodies induce differential effects in fibroblasts from celiac disease patients and from healthy subjects.
Paolella G; Lepretti M; Barone MV; Nanayakkara M; Di Zenzo M; Sblattero D; Auricchio S; Esposito C; Caputo I
Amino Acids; 2017 Mar; 49(3):541-550. PubMed ID: 27613408
[TBL] [Abstract][Full Text] [Related]
31. Celiac disease and autoimmunity.
Troncone R; Discepolo V
J Pediatr Gastroenterol Nutr; 2014 Jul; 59 Suppl 1():S9-S11. PubMed ID: 24979198
[TBL] [Abstract][Full Text] [Related]
32. Sampling of proximal and distal duodenal biopsies in the diagnosis and monitoring of celiac disease.
Caruso R; Marafini I; Del Vecchio Blanco G; Fina D; Paoluzi OA; Colantoni A; Sedda S; Pallone F; Monteleone G
Dig Liver Dis; 2014 Apr; 46(4):323-9. PubMed ID: 24394601
[TBL] [Abstract][Full Text] [Related]
33. Modeling of celiac disease immune response and the therapeutic effect of potential drugs.
Demin OO; Smirnov SV; Sokolov VV; Cucurull-Sanchez L; Pichardo-Almarza C; Flores MV; Benson N; Demin OV
BMC Syst Biol; 2013 Jul; 7():56. PubMed ID: 23826972
[TBL] [Abstract][Full Text] [Related]
34. Intestinal T-cell responses in celiac disease - impact of celiac disease associated bacteria.
Sjöberg V; Sandström O; Hedberg M; Hammarström S; Hernell O; Hammarström ML
PLoS One; 2013; 8(1):e53414. PubMed ID: 23326425
[TBL] [Abstract][Full Text] [Related]
35. Interplay between Type 2 Transglutaminase (TG2), Gliadin Peptide 31-43 and Anti-TG2 Antibodies in Celiac Disease.
Martucciello S; Sposito S; Esposito C; Paolella G; Caputo I
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456177
[TBL] [Abstract][Full Text] [Related]
36. Interleukin 15 and CD4⁺ T cells cooperate to promote small intestinal enteropathy in response to dietary antigen.
Korneychuk N; Ramiro-Puig E; Ettersperger J; Schulthess J; Montcuquet N; Kiyono H; Meresse B; Cerf-Bensussan N
Gastroenterology; 2014 Apr; 146(4):1017-27. PubMed ID: 24361466
[TBL] [Abstract][Full Text] [Related]
37. Gliadin activates HLA class I-restricted CD8+ T cells in celiac disease intestinal mucosa and induces the enterocyte apoptosis.
Mazzarella G; Stefanile R; Camarca A; Giliberti P; Cosentini E; Marano C; Iaquinto G; Giardullo N; Auricchio S; Sette A; Troncone R; Gianfrani C
Gastroenterology; 2008 Apr; 134(4):1017-27. PubMed ID: 18395083
[TBL] [Abstract][Full Text] [Related]
38. Autoantibodies in coeliac disease: tissue transglutaminase--guilt by association?
Sollid LM; Molberg O; McAdam S; Lundin KE
Gut; 1997 Dec; 41(6):851-2. PubMed ID: 9462222
[No Abstract] [Full Text] [Related]
39. Interleukin-15, a master piece in the immunological jigsaw of celiac disease.
Meresse B; Korneychuk N; Malamut G; Cerf-Bensussan N
Dig Dis; 2015; 33(2):122-130. PubMed ID: 25925912
[TBL] [Abstract][Full Text] [Related]
40. IL-33 Alarmin and Its Active Proinflammatory Fragments Are Released in Small Intestine in Celiac Disease.
Perez F; Ruera CN; Miculan E; Carasi P; Dubois-Camacho K; Garbi L; Guzman L; Hermoso MA; Chirdo FG
Front Immunol; 2020; 11():581445. PubMed ID: 33133101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
